The first stop for professional medicines advice

Medicine

324 results

RelevanceNewest firstOldest firstTitle
Applied filters

Handling and preparation of sotrovimab

14 December 2021An outline process and supporting materials to help Trusts deploy sotrovimab

Giving CosmoFer® (iron dextran) as a total dose infusion

14 December 2021Use a stepped process to safely and rapidly correct iron deficiency in adults over 14 years in hospital.

Choosing an oral vitamin D preparation for vegetarians or vegans

13 December 2021An explanation as to why the source of vitamin D, or inactive ingredients (excipients) in products, may make preparations unsuitable for vegetarians or vegans.

Using miconazole oral gel with statins

30 November 2021Treatment of oral thrush (candidiasis) with miconazole is complicated by concurrent HMG-CoA reductase (statin) use because of potential for drug interactions.

Supply and/or administration of Controlled Drugs under a PGD

16 November 2021This article summarises the legal position on the supply and/or administration of controlled drugs under PGDs.

Using potassium permanganate for skin conditions or wound care

15 November 2021Potassium permanganate is a chemical product. We review the evidence for using it in wound care and highlight the risk of severe harm associated with wrong use.

Using oral anticoagulants during breastfeeding

2 November 2021Thromboembolic disease management whilst breastfeeding is challenging. Warfarin is the preferred choice. Guidance on using DOACs is also provided.

Considering sodium content of medicines

26 October 2021High sodium content can make some medicines unsuitable for patients on a salt-restricted diet. Alternative products exist for a range of conditions.

Choosing between oral fidaxomicin options

20 October 2021Local decision makers should choose between the options for giving fidaxomicin orally. Licensing status and other factors affect decision making.

Switching between mesalazine oral tablet preparations

19 October 2021An overview of differences between mesalazine tablet preparations and clinical considerations when switching between preparations.